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Purpose: Lysyl oxidase-like 1 (LOXL1) is a copper-dependant amine oxidase that plays an essential role in elastogenesis.
Two non-synonymous single-nucleotide polymorphisms of LOXL1, R141L (rs1048661) and G153D (rs3825942), have
been reported to significantly increase susceptibility to exfoliation glaucoma (XFG). To evaluate the impact of the R141L
and G153D variations on the amine oxidase activity of LOXL1, we generated four different haplotypes of LOXL1 with
R141L and G153D and assessed the amine oxidase activity of the LOXL1 variant proteins.
Methods: The four different haplotype variants of LOXL1 were created by oligonucleotide-directed mutagenesis in an
LOXL1 expression vector. Recombinant LOXL1 variant proteins were purified by nickel-affinity chromatography. The
amine oxidase activities of the LOXL1 variant proteins were assessed using peroxidase-coupled fluorometric assays.
Results: All of the haplotype variants of LOXL1 (141R-153G, 141R-153D, 141L-153G, and 141L-153D) showed β-
aminopropionitrile-inhibitable amine oxidase activity toward elastin, type I collagen, and cadaverine, indicating that each
LOXL1 variant functions as an amine oxidase. However, there were no significant differences in amine oxidase activity
between the LOXL1 haplotype variants toward the tested substrates.
Conclusions: The R141L and G153D variations in the NH2-terminal region of LOXL1 do not affect the amine oxidase
activity of LOXL1. This is consistent with recent genetic findings on the reversal of risk alleles of R141L and G153D in
different ethnic backgrounds. Our results suggest that other unknown genetic factors or molecular mechanisms may be
more relevant to the development of XFG.
Lysyl oxidase-like 1 (LOXL1) was originally reported as
a novel human gene with amino acid sequence homology to
the COOH-terminus of lysyl oxidase (LOX) [1,2]. LOX is a
copper-dependent amine oxidase responsible for the lysine-
derived cross-links in collagen and elastin, modulating the
essential  step  for  the  biogenesis  of  fibrillar  extracellular
matrix in most tissues [3]. The LOX gene family consists of
five paralogs (LOX,LOXL1,LOXL2,LOXL3, and LOXL4) in
humans,  each  containing  a  copper-binding  motif,  lysyl-
tyrosyl-quinone (LTQ) residues, and a cytokine receptor-like
(CRL) domain in the highly conserved COOH-terminus. We
have previously shown that each of the LOX-like proteins
functions as an amine oxidase [4-7], but functional differences
of  these  LOX  family  proteins  have  not  been  clearly
determined. Recently, Loxl1 null mice were found to have
significantly reduced levels of desmosine in various tissues,
indicating that LOXL1 serves as the primary cross-linking
enzyme for formation, maintenance, and remodeling of elastic
fibers [8].
Exfoliation glaucoma (XFG) occurs in the context of the
exfoliation  syndrome  (XFS),  characterized  by  progressive
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accumulation of abnormal microfibrillar material throughout
the anterior segment of the eye and various ocular tissues [9].
XFG is the most common identifiable cause of secondary
open-angle glaucoma worldwide, causing rapid progression
of glaucomatous optic neuropathy with a high resistance to
medical treatments [9]. The abnormal microfibrillar deposits
in  XFG  are  composed  of  a  crosslinked  and  insoluble
glycoprotein-proteoglycan  complex,  predominantly  with
epitopes of elastic fibers [10], suggesting the relevance of
LOXL1 to the formation of the exfoliative material. In fact,
using direct mass spectrometry, LOXL1 was identified as a
component of the exfoliative material surgically isolated from
XFG patients [11]. Later, using atomic force microscopy-
based imaging, LOX1 was found to be localized around the
fibrous protein material on the lens capsule surface [12].
In a genome-wide search for genetic risk factors of XFG,
two  non-synonymous  single-nucleotide  polymorphisms
(SNPs) in exon 1 of LOXL1, rs1048661G/T (R141L) and
rs3825942G/A (G153D), were identified with the G allele as
a risk allele at both SNPs in Nordic populations [13]. Of four
possible  haplotypes  involving  the  two  SNPs,  only  three
haplotypes (GG, GA, and TG) were detected, and the TA
haplotype was not observed in either the XFG or control
group.  Relative  to  the  GA  haplotype,  the  GG  and  TG
haplotypes  showed  odds  ratios  of  27.05  and  8.90,
respectively,  for  the  incidence  of  XFG  [13].  Subsequent
studies confirmed the association of these SNPs with XFG in
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265different populations, including German, Italian, Caucasian
Australian, and United States populations [14-17].
To  evaluate  the  effects  of  the  R141L  and  G153D
variations  on  the  amine  oxidase  activity  of  LOXL1,  we
constructed  the  GG,  GA,  TG,  and  TA  haplotype  variants
across rs1048661 and rs3825942 by oligonucleotide-directed
mutagenesis, each corresponding to 141R-153G, 141R-153D,
141L-153G, and 141L-153D in the amino acid sequence of
LOXL1,  respectively.  The  LOXL1  variant  proteins  were
expressed and purified as hexa-histidine tagged recombinant
proteins. The amine oxidase activities of the purified LOXL1
variant  proteins  were  accessed  using  in  vitro  peroxidase-
coupled  fluorometric  assays.  The  four  different  haplotype
variants of LOXL1 did not show significant differences in
amine  oxidase  activity  toward  elastin,  type  I  collagen,  or
cadaverine.
METHODS
Construction  of  expression  plasmids  for  four  different
LOXL1 haplotypes: The expression plasmid for LOXL1 was
generated  as  previously  described  [4].  A  pET21a-derived
expression plasmid containing the nucleotide sequence from
codon 135D to the COOH-terminus was used as a template
for oligonucleotide-directed mutagenesis. The mutagenesis
was  performed  using  the  QuikChange  II  site-directed
mutagenesis kit (Stratagene, La Jolla, CA) according to the
manufacturer’s  protocol.  Thermocycling  consisted  of  16
cycles at 95 °C for 30 s, 58 °C for 1 min, and 68 °C for 7 min.
The  sequences  of  the  oligonucleotide  primers  used  for
mutagenesis are listed in Table 1. The nucleotide sequences
of  all  resulting  constructs  were  confirmed  by  DNA-
sequencing analysis using the BigDye™ Terminator Cycle
Sequencing Ready Reaction Kit (Applied Biosystems, Foster
City, CA) according to the manufacturer’s protocol.
Purification and refolding of the haplotype variant proteins
of LOXL1: Purification and refolding of the four different
haplotype  proteins  of  LOXL1  were  performed  as  we
previously  described  for  the  LOX  family  proteins  [4,7].
Briefly, the pET21a-derived expression constructs harboring
the four different haplotypes of LOXL1 were introduced into
the Escherichia coli strain BL21(DE3; Novagen, Darmstadt,
Germany). After induction with 1 mM isopropyl-1-thio-β-D-
galactopyranoside (IPTG) at 37 °C, the transformed bacterial
cells were lysed in a buffer containing 50 mM Tris, pH 8.0,
1  mM  EDTA,  100  mM  NaCl,  1  mM  PMSF,  1  mg/ml
lysozyme, 1% Triton X-100, and 0.1 mg/ml DNase. After
centrifugation, inclusion bodies were homogenized in a buffer
containing 6 M urea, 10 mM K2HPO4, pH 8.2, and 3 mM β-
mercaptoethanol.  The  LOXL1  variant  proteins  were  then
purified using Ni-NTA agarose resins (Qiagen, Valencia, CA)
according to the manufacturer’s protocol. For refolding of the
LOXL1 variant proteins, stepwise dialysis was performed in
a buffer containing 10 mM K2HPO4, pH 9.6, 200 μM CuCl2,
and 2% sodium N-lauroylsarcosinate and then in a buffer
containing 10 mM K2HPO4, pH 9.6, and 5 μM CuCl2. The
protein samples were further dialyzed in 10 mM K2HPO4, pH
9.6. The dialyzed proteins were lyophilized in the presence of
10 mM trehalose using a freeze dryer (Labconco, Kansas City,
MO). All purification procedures were performed at 4 °C. The
purity  and  sizes  of  the  LOXL1  variant  proteins  were
determined  using  sodium  dodecyl  sulfate-PAGE  (SDS–
PAGE).
Amine oxidase assays for the haplotype variant proteins of
LOXL1: Amine oxidase activity of the haplotype variants of
LOXL1  was  assessed  using  a  peroxidase-coupled
fluorometric assay with the Amplex red hydrogen peroxide
assay  kit  (Molecular  Probes,  Eugene,  OR),  as  previously
described [18]. Each reaction contained 10 μg of a purified
LOXL1 variant protein and 20 pmol of substrate in a reaction
volume  of  200  μl.  Parallel  assays  were  performed  in  the
absence or presence of 1 mM β-aminopropionitrile (BAPN)
for 2 h at 37 °C. Bovine neck ligament elastin, calfskin type I
collagen,  and  cadaverine  (1,5-pentanediamine;  Sigma-
Aldrich, St. Louis, MO) were used as substrates for amine
oxidase  assays.  Fluorescence  was  measured  using  a
fluorescence microplate reader (BioTek, Winooski, VT) with
excitation and emission wavelengths of 560 nm and 590 nm,
respectively. Total amine oxidase activity was expressed as
nM of H2O2 produced per μg of the LOXL1 variant protein,
calculated by interpolation with fluorescence values from an
H2O2 calibration curve.
RESULTS
We previously reported the expression and purification of an
enzymatically active form of human LOXL1 as a recombinant
protein  (LOXL-p1)  [4].  The  NH2-terminal  site  of  the
previously reported LOXL-p1 [4] was deduced from amino
TABLE 1. LIST OF PRIMERS USED FOR OLIGONUCLEOTIDE-DIRECTED MUTAGENESIS.
SNP Amino acid change Sequence Tm (°C )
rs1048661 R→L F-5’- gggcatggcccTggcccgcacctcc -3’ 76
    R-5’- ggaggtgcgggccAgggccatgccc -3’ 76
rs3825942 G→D F-5’- acggcacggggActccgcctcctcg -3’ 75
    R-5’- cgaggaggcggagTccccgtgccgt -3’ 75
          In the sequence, the bases mismatched with the template are indicated in capital letters.
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266acid sequence homology with the bovine LOXL1 protein, of
which potential NH2-terminal proteolytic cleavage sites were
suggested by incubation with bone morphogenetic protein
(BMP)-1  [19].  Using  the  previously  reported  expression
construct of LOXL-p1 (141R-153G haplotype) as a template,
we generated three additional haplotype variants at R141L
and  G153D  by  a  series  of  oligonucleotide-directed
mutagenesis (Figure 1). All of the expected haplotype variants
of  LOXL1  (141R-153G,  141R-153D,  141L-153G,  and
141L-153D)  contain  a  copper-binding  domain,  a  CRL-
domain, and LTQ residues (477K and 511Y) in the COOH-
terminal region, which are considered prerequisites for amine
oxidase activity of the LOX family proteins.
Upon induction with 1 mM IPTG in E. coli, all expression
constructs of the four different LOXL1 variants showed high
levels of expression. However, the LOXL1 variant proteins
were within inclusion bodies. The insoluble fractions were
solubilized  with  6  M  urea,  and  then  the  LOXL1  variant
proteins  were  purified  by  nickel-chelating  affinity
chromatography using a hexa-histidine tag attached at the
COOH-termini of the variant proteins. To refold the LOXL1
variant proteins denatured by urea during purification, the
protein samples were subjected to stepwise dialysis in the
presence of N-lauroylsarcosinate and Cu2+. The apparent sizes
of the purified recombinant LOXL1 variant proteins were in
good agreement with the deduced molecular mass, 56 kDa,
and were over 95% pure on SDS–PAGE gels (Figure 2).
Amine oxidase activity of the four different haplotype
variants  of  LOXL1  was  evaluated  using  physiologic
substrates of LOXL1, elastin and type I collagen, as well as
cadaverine, an artificial substrate with a diamine structure. All
four  haplotype  variants  of  LOXL1  showed  significantly
higher  levels  of  amine  oxidase  activity  in  the  absence  of
BAPN than in the presence of BAPN, a well known specific
inhibitor of LOX and LOXL1, indicating that the purified
LOXL1 variant proteins had BAPN-inhibitable amine oxidase
activity toward the tested substrates (Figure 3). Regardless of
the haplotype, the LOXL1 variant proteins showed higher
activities toward cadaverine than elastin and type I collagen.
However,  there  were  no  significant  differences  in  amine
oxidase  activity  between  the  different  haplotype  variants
toward any of the tested substrates (Figure 3), suggesting that
the 141R and 153G variations in the NH2-terminal region do
not affect the amine oxidase activity of LOXL1.
DISCUSSION
Since the first report on genetic association of rs1048661 and
rs3825942 with XFG in Nordic populations [13], reversal of
Figure 1. Construction of the LOXL1 expression constructs for the four different haplotypes. A: A schematic diagram of the recombinant
LOXL1 protein expected from the LOXL1 expression constructs. The recombinant LOXL1 protein contains the amino acid sequence from
codon 135D to the COOH-terminus with a hexa-histidine tag at the end. The approximate positions of R141L and G153D in the propeptide
region are indicated with asterisks. B: DNA sequencing analysis of the mutated LOXL1 expression constructs. The GG haplotype construct
(141R-153G) was used as a template for oligonucleotide-directed mutagenesis. The amino acid sequence corresponding to each haplotype is
indicated in parentheses. The nucleotide sequences at rs1048661 and rs3825942 are indicated with arrows.
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267the  risk  alleles  have  been  reported  in  various  ethnic
backgrounds. For instance, the G allele of rs1048661 was
identified  as  a  risk  allele  in  most  populations  studied,
including Nordic, United States, German, Italian, Caucasian
Australian,  Finnish,  and  black  South  African  populations
[13-17,20], while the opposite T allele of  rs1048661 was
reported to increase the risk of XFG in Japanese and Chinese
populations  [21,22].  The  G  allele  of  rs3825942  has  been
reported as a risk allele in most ethnic backgrounds studied
[13-17,21-26];  however,  the  A  allele  of  rs3825942  was
identified as a risk allele for XFG in black South Africans
[20]. In addition, an association between rs1048661 and XFG
was  not  observed  in  some  populations,  including  Indian,
Chinese,  Latin  American,  and  United  States  populations
[23-26]. These inconsistent genetic findings suggest that the
R141L and G153D variations may not be causative factors in
the development of XFG. To investigate the effects of the
R141L and G153D variations on amine oxidase activity of
LOXL1,  we  generated  four  different  haplotype  variant
proteins with R141L and G153D. In amine oxidase assays
using the purified LOXL1 variant proteins, the four different
haplotypes did not show significantly different amine oxidase
activities toward elastin, type I collagen, or cadaverine. These
assay results explain the discrepant genetic findings on the
association  of  rs1048661  and  rs3825942  with  XFG  in
different ethnic backgrounds, suggesting that other unknown
genetic factors or molecular mechanisms may be more critical
in the development of XFG.
Compared  to  the  highly  conserved  COOH-terminal
domains of the LOX family proteins, LOXL1 shows little
amino  acid  sequence  homology  with  LOX  in  the  NH2-
terminal region. Both LOX and LOXL1 are secreted into the
Figure 2. Expression and purification of the four different haplotype
proteins  of  LOXL1.  Each  lane  contains  approximately  3  μg  of
purified  recombinant  LOXL1  protein  of  the  141L-153G,
141L-153D, 141R-153G, or 141R-153D haplotype. Lane M contains
a molecular mass standard.
extracellular matrix and become enzymatically active after
proteolytic cleavage of the NH2-terminal propeptide region by
BMP-1 [19,27]. Using a recombinant protein approach, the
NH2-terminal propeptide region (codons 1 to 303) of LOXL1
was  shown  to  play  a  critical  role  in  interaction  with
Figure 3. Amine oxidase activity of the four different haplotype
variants of LOXL1 toward elastin, type I collagen, or cadaverine.
The reactions without BAPN are in gray, and the reactions with
BAPN are in white. The amine oxidase activity is expressed as nM
of H2O2 produced per μg of the LOXL1 variant protein. Standard
deviations are indicated in each graph, and the p-values between the
reactions with and without BAPN are less than 0.05 in all cases
tested.
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268tropoelastin, directing the LOXL1 protein onto elastic fibers
[28]. Thus, the presence of the R141L and G153D variations
in the propeptide region raises a possibility that these missense
variations may be important in directing LOXL1 onto the sites
of  elastogenesis  by  influencing  its  interaction  with
tropoelastin. Alternatively, the missense variations of R141L
and G153D may affect the interaction of LOXL1 with the
scaffolding proteins required for elastogenesis. For instance,
fibulin-5, a microfibril-associated protein, is critical for elastic
fiber  organization,  functioning  as  a  scaffold  element  for
elastogenesis  [29,30].  Further,  fibulin-5  colocalizes  and
interacts  with  LOXL1,  through  the  NH2-terminal  region
unique to LOXL1 [8]. These findings suggest that the R141L
and G153D variations may affect the interaction of LOXL1
with fibulin-5, thus leading to disorganized formation and
abnormal  aggregation  of  elastic  fibers.  Further  molecular
studies on the effects of R141L and G153D on proteolytic
processing of LOXL1 or interactions with tropoelastin and the
microfibril-associated proteins will be necessary for resolving
these intriguing questions.
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